Zhongyuan Wang
Guangdong Provincial Key Laboratory Of Regional Immunity And Diseases
Shenzhen, China
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
WDR54 exerts oncogenic roles in T-cell acute lymphoblastic leukemia.
Journal: Cancer science
Published: January 07, 2023
YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia.
Journal: Blood advances
Published: January 03, 2023
Sulfur-Coordinated Organoiridium(III) Complexes Exert Breast Anticancer Activity via Inhibition of Wnt/β-Catenin Signaling.
Journal: Angewandte Chemie (International ed. in English)
Published: November 10, 2020
The CK1δ/ε-AES axis regulates tumorigenesis and metastasis in colorectal cancer.
Journal: Theranostics
Published: September 29, 2020
Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity.
Journal: Pharmacological research
Published: April 03, 2020
CDDO-Me Elicits Anti-Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex.
Journal: The Journal of pharmacology and experimental therapeutics
Published: October 28, 2019
Longdaysin inhibits Wnt/β-catenin signaling and exhibits antitumor activity against breast cancer.
Journal: OncoTargets and therapy
Published: February 22, 2019
Salinomycin exerts anti-colorectal cancer activity by targeting the β-catenin/T-cell factor complex.
Salinomycin exerts anti-colorectal cancer activity by targeting the β-catenin/T-cell factor complex.
Journal: British journal of pharmacology
Published: December 10, 2018
Emetine exhibits anticancer activity in breast cancer cells as an antagonist of Wnt/β‑catenin signaling.
Journal: Oncology reports
Published: November 19, 2018
Last Updated: 09/26/2026